NCT05886075: A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors |
|
|
| Recruiting | 1 | 24 | RoW | Recombinant oncolytic herpes simplex virus type 1 (R130), Oncolytic virus | Shanghai Yunying Medical Technology, The PLA Navy Anqing Hospital | Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer, Small Cell Lung Cancer, Sarcoma, Colorectal Cancer, Gastric Cancer, Liver Cancer, Breast Cancer, Pancreatic Cancer, Head and Neck Cancer, Ovarian Cancer | 03/25 | 03/25 | | |
